BioHealth News Archive

Empower Therapeutics Inc. Granted Exclusive License to Develop Digital Therapeutics Platform for Neuromodulation of Pain Sensitivity

Empower Therapeutics Inc. Granted Exclusive License to Develop Digital Therapeutics Platform for Neuromodulation of Pain Sensitivity

BALTIMORE, Aug. 19, 2021 /PRNewswire/ -- Empower Therapeutics Inc., a Baltimore-based startup, has secured worldwide, exclusive rights to a simple, reliable brainwave biomarker for pain…

Read More

Alexandria Chairman Joel Marcus On Emerging Cities, Megacampuses And ‘Hucksters’

When Joel Marcus, a trained accountant and biotech industry lawyer, started lab real estate giant Alexandria Real Estate Equities in the 1990s, the sure…

Read More
Implementing GMP For Early-Phase Development With Cartesian Therapeutics Co-Founder And CEO Dr Murat Kalayoglu

Implementing GMP For Early-Phase Development With Cartesian Therapeutics Co-Founder And CEO Dr Murat Kalayoglu

A key factor in the success of a developing drug or therapy is the success of early clinical trials. A focus on Good Manufacturing…

Read More

Johns Hopkins Tech Ventures startups saw $1B in investment in fiscal 2021 – Baltimore Business Journal

Startups with ties to Johns Hopkins ties have contributed significantly to the highest-ever amounts of capital being raked in across Maryland and beyond. For…

Read More
Johns Hopkins Technology Ventures – Fiscal Year 2021 Annual Report

Johns Hopkins Technology Ventures – Fiscal Year 2021 Annual Report

I'm pleased to share with you JHTV's annual report for Fiscal Year 2021. The pandemic made FY21 an unusual one, but the JHTV team…

Read More
BXP Life Sciences Expands with Montgomery County, Maryland Acquisition – BioHealth Capital Region

BXP Life Sciences Expands with Montgomery County, Maryland Acquisition – BioHealth Capital Region

BOSTON – July 27, 2021 – Boston Properties, Inc. (NYSE: BXP), the largest publicly traded developer, owner, and manager of Class A office properties in…

Read More
50 Over 50 2021: Vision

50 Over 50 2021: Vision

Armed with brilliant ideas, experience and a determination to disrupt, these 50 women are making an impact on society and culture through healthcare, robotics,…

Read More

Sonosa Medical Spins Out of the MDC Studio

The MDC Studio is pleased to announce the spin-out of the company, Sonosa Medical, Inc., as an independent entity. Founded in 2019, Sonosa Medical…

Read More
Join United Therapeutics Corporation…..

Join United Therapeutics Corporation…..

This is what it is ALL about - the largest 3D printed hydrogel. This lung model can be perfused and ventilated and this blueprint…

Read More
NCI Technology Transfer Center (TTC) Communications for Industry Partners

NCI Technology Transfer Center (TTC) Communications for Industry Partners

Public reporting burden for this collection of information is estimated to average 10 minutes per response, including the time for reviewing instructions, searching existing…

Read More
FZata Announces First-in-Class “Live Biologics In A Pill” Platform Entering Manufacturing Phase · BioBuzz

FZata Announces First-in-Class “Live Biologics In A Pill” Platform Entering Manufacturing Phase · BioBuzz

FZata, Inc. is developing our ground-breaking “Live Biologics In A Pill” platform for oral delivery of live biologics. Live Biologics In A Pill will…

Read More
How these 50 innovators on our DC Inno on Fire list are heating up the startup universe – Washington Business Journal

How these 50 innovators on our DC Inno on Fire list are heating up the startup universe – Washington Business Journal

We’re taking a closer look at each of the 50 winners of our 2021 Inno on Fire honorees.   {iframe}https://www.bizjournals.com/washington/news/2021/08/13/50-inno-on-fire-awards-closer-look-2021.html?ana=e_wash_bn_exclusive_exclusive&j=90567805&t=Breaking%20News&mkt_tok=NjczLVVXWS0yMjkAAAF-314prdtJe57vr-MSfP9bXpcH-4SwqQ8fvYZ_ctcCGZQuE9CF_8xZhWQFqsGTgfF3MuynnTl6xPJqiiJdxjTf7uBo2g6pIQ_s_cAWeeIwd6sn9pFn{/iframe}

Read More
FDA new drug applications to cost more than $3M in 2022

FDA new drug applications to cost more than $3M in 2022

Starting in 2022, drugmakers filing new drug applications with clinical data will have to pay the FDA $3.1 million. The FDA's fee for new…

Read More
How A Disconnected Biohealth Ecosystem Became The Next Big Thing – YouTube

How A Disconnected Biohealth Ecosystem Became The Next Big Thing – YouTube

Jeff Galvin, CEO of American Gene Technologies and Rich Bendis, CEO and President of BioHealth Innovation, Inc. have a fireside chat about the rapid…

Read More
Dr. Anne Khademian ,Executive Director, The Universities at Shady Grove, Welcomes Rich Bendis to #ThisIsUSG Podcast”

Dr. Anne Khademian ,Executive Director, The Universities at Shady Grove, Welcomes Rich Bendis to #ThisIsUSG Podcast”

In this episode of #ThisIsUSG, BioHealth Innovation President and CEO Rich Bendis joins Dr. Anne Khademian for a discussion about BioHealth Innovation's role in…

Read More